Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago

Stopped The comparator product was withdrawn from the brazilian market not being possible to conduct the design regarding initially planned.

Conditions

• Acute Lumbago

Interventions

• DRUG: meloxicam/cyclobenzaprine hydrochloride
• DRUG: meloxicam - Movatec®
• DRUG: cyclobenzaprine - Miosan®

Sponsor

Eurofarma Laboratorios S.A.